Home › Schizophrenia › Arizona
Schizophrenia clinical trials in Arizona
4 studies for Schizophrenia are looking for participants at sites in Arizona.
Cities in Arizona
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Southwest Autism Research and Resource Center, Phoenix
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 25, 2026 · NCT06229210A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Local Institution - 0163, Phoenix
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 22, 2026 · NCT0742440452-week Open Label Safety-Tolerability Study
- Chandler Clinical Trials, Chandler
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 9, 2026 · NCT07369154Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Phoenix
RecruitingPhase 3Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Dec 19, 2024 · NCT05184335From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.